Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20181814
Conclusion of this study
Coffee consumption appears to have beneficial effects on subclinical inflammation and HDL cholesterol, whereas no changes in glucose metabolism were found in our study. Furthermore, many coffee-derived methylxanthines and caffeic acid metabolites appear to be useful as biomarkers of coffee intake.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study